Author(s)
Dharmendra Jain, PhD
Lisa K Peterson, PhD, D(ABMLI)
Associate Professor, Pathology
Medical Directory, Immunology
University of Utah School of Medicine
ARUP Laboratories
Salt Lake City, Utah
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
· describe the differences that exist in nomenclature and interpretation of HEp-2 IFA antibody results;
· recognize gaps in the knowledge regarding the clinical significance of cytoplasmic HEp-2 IFA staining patterns;
· identify opportunities for improving HEp-2 FA nomenclature and reporting; and
· discuss the role of cytoplasmic HEp-2 IFA staining associated with anti-Ribo P antibodies in the diagnosis of SLE.